Balyasny Asset Management LLC Teva Pharmaceutical Industries LTD Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Balyasny Asset Management LLC holds 34,000 shares of TEVA stock, worth $751,060. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,000

Previous 3,742,969 99.09%

Holding current value

$751,060

Previous $60.8 Million 98.99%

% of portfolio

0.0%

Previous 0.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.81 - $18.96 $23 Million - $27.6 Million	-1,454,959 Reduced 38.87%	2,288,010 $41.2 Million
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $7.94 Million - $10.8 Million	620,971 Added 19.89%	3,742,969 $60.8 Million
Q1 2024 May 13, 2024	BUY	$10.67 - $14.43 $33.3 Million - $45.1 Million	3,121,998 New	3,121,998 $44.1 Million
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $4.19 Million - $5.99 Million	559,518 New	559,518 $5.71 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $713,634 - $970,577	85,363 Added 4.73%	1,888,903 $16.7 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $14.3 Million - $17.1 Million	1,803,540 New	1,803,540 $16.4 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $12.8 Million - $18.1 Million	1,735,919 Added 192.13%	2,639,446 $19.8 Million
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $6.48 Million - $8.3 Million	883,783 Added 4476.21%	903,527 $8.48 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $155,977 - $201,191	19,744 New	19,744 $158,000
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $13 Million - $25.1 Million	-1,596,027 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $12.7 Million - $16.3 Million	813,862 Added 104.05%	1,596,027 $25 Million
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $12.3 Million - $20.1 Million	-844,463 Reduced 51.91%	782,165 $12.1 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $14.1 Million - $17.2 Million	670,720 Added 70.17%	1,626,628 $35 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $10.5 Million - $15.4 Million	-624,548 Reduced 39.52%	955,908 $23.2 Million
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $17.1 Million - $22.6 Million	1,024,166 Added 184.11%	1,580,456 $27 Million
Q4 2017 Feb 14, 2018	SELL	$11.23 - $19.1 $12.2 Million - $20.8 Million	-1,089,636 Reduced 66.2%	556,290 $10.5 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $25.4 Million - $52.9 Million	1,645,926	1,645,926 $29 Million

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.5B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Teva Pharmaceutical Industries LTD Transaction History